Trading Signals: CAPR Stock Price Prediction and Forecast (Tue. Apr. 1, 2003 - Fri. Jul. 2, 2021)(Capricor Therapeutics Inc)
| CAPR latest price $2415.0000 (1.9%) ($2340.0000 - $2420.0000) on Thu. Aug. 21, 2008. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 3.13% (three month average) | RSI | 78 | Latest Price | $2415.0000(1.9%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | CAPR advances 0.4% a day on average for past five trading days. | Weekly Trend | CAPR advances 4.9% a week on average for past two weeks. | Market Behavior | Normal for large cap. Normal for small cap. | Correlated ETFs | Broad market will support CAPR advance at 0% a week (0% probability) PEJ(3%) EWI(2%) EWP(2%) IWM(2%) USO(2%) | Factors Impacting CAPR price | CAPR will decline at least -1.565% in a week (0% probabilities). EWY(-1%) XLU(0%) XLP(0%) VWO(0%) TLT(0%) | Explanation | The rally is not sustainable and not supported by the broad market. | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.565% (StdDev 3.13%) | Hourly BBV | 0 () | Intraday Trend | 2.3% | | | |
|
5 Day Moving Average | $2427(-0.49%) | 10 Day Moving Average | $2436.55(-0.88%) | 20 Day Moving Average | $2284.89(5.69%) | To recent high | -8% | To recent low | 28.1% | Market Cap | $47.57b | | | | Capricor Therapeutics, Inc. engages in the discovery, development and commercialization of first-in-class biological therapies for the treatment of cardiac and other serious medical conditions. Its product candidate consists of CAP-1002, Cenderitide, Exosomes, CAP-1001, CU-NP and CSps. The company was founded in August 2005 and is headquartered in Beverly Hills, CA. |